These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 23943906)

  • 1. Pretreatment patient comorbidity and tobacco use increase cost and risk of postoperative complications after esophagectomy at a high-volume cancer center.
    Murphy CC; Incalcaterra JR; Albright HW; Correa AM; Swisher SG; Hofstetter WL
    J Oncol Pract; 2013 Sep; 9(5):233-9. PubMed ID: 23943906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The cost burden of clinically significant esophageal anastomotic leaks-a steep price to pay.
    Agzarian J; Visscher SL; Knight AW; Allen MS; Cassivi SD; Nichols FC; Shen KR; Wigle D; Blackmon SH
    J Thorac Cardiovasc Surg; 2019 May; 157(5):2086-2092. PubMed ID: 30558876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hospital costs of complications after esophagectomy for cancer.
    Goense L; van Dijk WA; Govaert JA; van Rossum PS; Ruurda JP; van Hillegersberg R
    Eur J Surg Oncol; 2017 Apr; 43(4):696-702. PubMed ID: 28012715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utilization of surgery in trimodality-eligible patients with locally advanced esophageal adenocarcinoma in a nonprotocol setting.
    Murphy CC; Hofstetter WL; Correa AM; Ajani JA; Komaki RU; Swisher SG
    Dis Esophagus; 2013; 26(7):708-15. PubMed ID: 23350713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes of preoperative chemotherapy with docetaxel, cisplatin, and 5-fluorouracil followed by esophagectomy in patients with resectable node-positive esophageal cancer.
    Watanabe M; Baba Y; Yoshida N; Ishimoto T; Nagai Y; Iwatsuki M; Iwagami S; Baba H
    Ann Surg Oncol; 2014 Sep; 21(9):2838-44. PubMed ID: 24715216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perioperative platin-based chemotherapy for locally advanced esophagogastric adenocarcinoma: Postoperative chemotherapy has a substantial impact on outcome.
    Glatz T; Bronsert P; Schäfer M; Kulemann B; Marjanovic G; Sick O; Hopt UT; Zirlik K; Makowiec F; Hoeppner J
    Eur J Surg Oncol; 2015 Oct; 41(10):1300-7. PubMed ID: 26253194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors and outcome of cervical anastomotic leakage after esophageal cancer surgery.
    Aminian A; Panahi N; Mirsharifi R; Karimian F; Meysamie A; Khorgami Z; Alibakhshi A
    J Cancer Res Ther; 2011; 7(4):448-53. PubMed ID: 22269408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accordion severity grading system: assessment of relationship between costs, length of hospital stay, and survival in patients with complications after esophagectomy for cancer.
    Carrott PW; Markar SR; Kuppusamy MK; Traverso LW; Low DE
    J Am Coll Surg; 2012 Sep; 215(3):331-6. PubMed ID: 22683069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiation dose does not influence anastomotic complications in patients with esophageal cancer treated with neoadjuvant chemoradiation and transhiatal esophagectomy.
    Koëter M; van der Sangen MJ; Hurkmans CW; Luyer MD; Rutten HJ; Nieuwenhuijzen GA
    Radiat Oncol; 2015 Mar; 10():59. PubMed ID: 25884226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Excess Cost and Predictive Factors of Esophagectomy Complications in the SEER-Medicare Database.
    Jiang R; Liu Y; Ward KC; Force SD; Pickens A; Sancheti MS; Javidfar J; Fernandez FG; Khullar OV
    Ann Thorac Surg; 2018 Nov; 106(5):1484-1491. PubMed ID: 29944881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Locally advanced esophageal adenocarcinoma: response to neoadjuvant chemotherapy and survival predicted by ([18F])FDG-PET/CT.
    Kauppi JT; Oksala N; Salo JA; Helin H; Karhumäki L; Kemppainen J; Sihvo EI; Räsänen JV
    Acta Oncol; 2012 May; 51(5):636-44. PubMed ID: 22208782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in body composition secondary to neoadjuvant chemotherapy for advanced esophageal cancer are related to the occurrence of postoperative complications after esophagectomy.
    Ida S; Watanabe M; Karashima R; Imamura Y; Ishimoto T; Baba Y; Iwagami S; Sakamoto Y; Miyamoto Y; Yoshida N; Baba H
    Ann Surg Oncol; 2014 Oct; 21(11):3675-9. PubMed ID: 24793436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intrathoracic anastomotic leakage and mortality after esophageal cancer resection: a population-based study.
    Rutegård M; Lagergren P; Rouvelas I; Lagergren J
    Ann Surg Oncol; 2012 Jan; 19(1):99-103. PubMed ID: 21769467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of treatment factors with surgical outcomes in tri-modality therapy for esophageal cancer.
    Shaikh T; Thomay A; Ruth K; Cohen SJ; Meyer JE
    J Surg Oncol; 2015 Nov; 112(6):629-33. PubMed ID: 26430952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The clinical and economic costs of delirium after surgical resection for esophageal malignancy.
    Markar SR; Smith IA; Karthikesalingam A; Low DE
    Ann Surg; 2013 Jul; 258(1):77-81. PubMed ID: 23426343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiorespiratory Comorbidity and Postoperative Complications following Esophagectomy: a European Multicenter Cohort Study.
    Klevebro F; Elliott JA; Slaman A; Vermeulen BD; Kamiya S; Rosman C; Gisbertz SS; Boshier PR; Reynolds JV; Rouvelas I; Hanna GB; van Berge Henegouwen MI; Markar SR
    Ann Surg Oncol; 2019 Sep; 26(9):2864-2873. PubMed ID: 31183640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neoadjuvant concurrent chemoradiotherapy for locally advanced esophageal cancer in a single high-volume center.
    Zanoni A; Verlato G; Giacopuzzi S; Weindelmayer J; Casella F; Pasini F; Zhao E; de Manzoni G
    Ann Surg Oncol; 2013 Jun; 20(6):1993-9. PubMed ID: 23274533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjuvant chemotherapy after esophagectomy: is there a role in the treatment of the lymph node positive thoracic esophageal squamous cell carcinoma?
    Lyu X; Huang J; Mao Y; Liu Y; Feng Q; Shao K; Gao S; Jiang Y; Wang J; He J
    J Surg Oncol; 2014 Dec; 110(7):864-8. PubMed ID: 24976079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Erythropoietin-alfa during neoadjuvant chemotherapy for locally advanced esophagogastric adenocarcinoma.
    Abbrederis K; Bassermann F; Schuhmacher C; Voelter V; Busch R; Roethling N; Sendler A; Siewert JR; Peschel C; Lordick F
    Ann Thorac Surg; 2006 Jul; 82(1):293-7. PubMed ID: 16798232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intraoperative and postoperative risk factors for anastomotic leakage and pneumonia after esophagectomy for cancer.
    Goense L; van Rossum PS; Tromp M; Joore HC; van Dijk D; Kroese AC; Ruurda JP; van Hillegersberg R
    Dis Esophagus; 2017 Jan; 30(1):1-10. PubMed ID: 27353216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.